April 30, 2025 a 08:31 pm

ZTS: Analysts Ratings - Zoetis Inc.

Zoetis Inc. Stock Overview

Zoetis Inc. continues to demonstrate stability in the animal health market with consistent growth in its stock ratings. The company's robust portfolio across various species and regions ensures a strong market position. Recent analyst evaluations suggest enduring confidence, primarily driven by its innovative product lines and increasing global demand for veterinary products.

Historical Stock Grades

The latest data, evaluated as of April 2025, indicates that Zoetis Inc. maintains a solid position with no "Sell" or "Strong Sell" recommendations. The company consistently receives a significant proportion of "Buy" ratings, underscoring strong market confidence. The consistent number of "Strong Buy" ratings further supports this stable market sentiment.

Rating Number of Recommendations Score Visualization
Strong Buy 5
Buy 10
Hold 5
Sell 0
Strong Sell 0
Analyst Ratings History Zoetis Inc. Stock Chart

Sentiment Development

Over recent months, the sentiment towards Zoetis Inc. has remained stable, without significant fluctuations. The ratings reveal stable market confidence with a slight increase in cautious hold ratings, indicating potential strategic shifts by analysts.

  • The total number of ratings has remained consistent from month to month, with marginal shifts in categories.
  • There is a noticeable consistency in "Strong Buy" ratings, suggesting sustained confidence in the company's growth prospects.
  • An uptick in "Hold" recommendations in past data highlights a balanced outlook amidst varying market conditions.

Percentage Trends

The percentage distribution among different ratings has been stable over recent months, reflecting a solid sentiment without drastic category migrations. This consistency indicates secure investor confidence, yet a slight increase in "Hold" percentages could suggest slight caution.

  • Strong Buy recommendations constituted approximately 20% of total ratings, signifying strong positive sentiment.
  • Buy recommendations account for around 40%, representing steady enthusiasm from analysts.
  • Hold recommendations have seen a marginal increase, bringing careful consideration into market sentiment.
  • Rising Hold percentages may indicate market acknowledgment of Zoetis Inc.'s growth but with some cautious observation.

Latest Analyst Recommendations

Recent analyst recommendations for Zoetis Inc. reflect a broad spectrum of assessments, largely maintaining previous ratings. This steadiness in evaluations underscores continued confidence in the company's performance in the animal health sector.

Date New Recommendation Last Recommendation Publisher
2025-04-14 Buy Buy Stifel
2025-02-27 Overweight Overweight Piper Sandler
2025-02-14 Overweight Overweight Barclays
2025-02-14 Overweight Overweight Morgan Stanley
2025-02-10 Overweight Overweight Piper Sandler

Analyst Recommendations with Change of Opinion

Fewer recent shifts in analyst opinions highlight overall confidence in Zoetis Inc.'s direction. However, earlier downgrades and upgrades captured in historical data depict considerable shifts in outlook and strategic recommendations.

Date New Recommendation Last Recommendation Publisher
2021-07-16 Market Perform Outperform Raymond James
2021-07-15 Market Perform Outperform Raymond James
2021-03-08 Outperform Market Perform Raymond James
2021-03-08 Buy Neutral B of A Securities
2021-03-07 Outperform Market Perform Raymond James

Interpretation

Based on recent ratings, Zoetis Inc. continues to be viewed favorably in the market. Analyst sentiment remains positive, with a substantial proportion of recommendations falling within the "Buy" and "Strong Buy" categories. Despite isolated caution implying potential market angst, the overall outlook remains robust. The lack of "Sell" ratings strengthens this affirmative stance.

Conclusion

In conclusion, Zoetis Inc. remains a solid contender in the animal health market with consistent positive analyst evaluations. While some increase in "Hold" recommendations may suggest conservative sentiment, the overarching trend is supportive of future growth. Given the absence of "Sell" recommendations, the company's financial health and operational stability continue to appeal to analysts and investors alike. Going forward, the strong foundational market position is expected to sustain both interest and positive evaluations.